US Broker Ratings

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Contender With 75% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is rapidly carving out a niche in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $4.96 billion, this New York-based..

Viatris Inc. (VTRS) Stock Analysis: Exploring an 18.42% Potential Upside in the Healthcare Sector

Viatris Inc. (NASDAQ: VTRS) is generating a buzz in the healthcare sector, with a potential upside of 18.42% that has caught the attention of investors. As a prominent player in..

TransMedics Group, Inc. (TMDX) Stock Analysis: Poised for a 30% Upside with Innovative Organ Care Solutions

TransMedics Group, Inc. (NASDAQ: TMDX) has recently captured investor attention with its cutting-edge advancements in organ transplant technology and an enticing potential upside of 30.01%. As a pioneer in the..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unpacking a 32% Upside Potential in the Biotech Sector

For investors seeking opportunities in the healthcare sector, Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing proposition. With a market capitalization of $4.56 billion, this biotechnology company is focused on..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 19% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, particularly in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to life sciences and..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 9.84% Potential Upside Amid Steady Market Position

AptarGroup, Inc. (NYSE: ATR), a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry, presents a compelling case for investors seeking stable growth opportunities coupled with..

Hologic, Inc. (HOLX) Stock Report: Analyzing Growth Potential Amidst Healthcare Innovation

Hologic, Inc. (HOLX), a prominent player in the healthcare sector focusing on medical instruments and supplies, stands out as a robust investment opportunity in the realm of women’s health diagnostics..

Cytokinetics, Incorporated (CYTK) Investor Outlook: Strong Analyst Buy Ratings and Nearly 95% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) is capturing investor attention with its robust market position in the biotechnology sector, as analysts project a significant potential upside of nearly 95%. As a late-stage..

Solventum Corporation (SOLV): Investor Outlook Amid 13.77% Potential Upside

Solventum Corporation (NASDAQ: SOLV) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. Based in the United States, this burgeoning company has quickly established a..

RadNet, Inc. (RDNT) Stock Analysis: A 24.67% Potential Upside in the Dynamic World of Diagnostics

RadNet, Inc. (NASDAQ: RDNT) stands out in the healthcare sector as a formidable player in diagnostics and research. With a market capitalization of $4.41 billion, RadNet is making significant strides..

BridgeBio Pharma, Inc. (BBIO) Investor Outlook: Analyzing the 32.83% Potential Upside Amidst a Robust Clinical Pipeline

BridgeBio Pharma, Inc. (BBIO), a commercial-stage biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating genetic diseases and cancers. Based in Palo Alto, California,..

Integer Holdings Corporation (ITGR) Stock Analysis: A 29.83% Upside Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors with its robust growth potential and strong analyst..

Tempus AI, Inc. (TEM) Stock Analysis: Harnessing a Robust 75.4% Revenue Growth in Health Information Services

Tempus AI, Inc. (TEM), a healthcare technology leader, is making waves in the Health Information Services industry with its impressive revenue growth and strategic collaborations. Headquartered in Chicago, the company..

Bausch + Lomb Corporation (BLCO) Stock Report: Navigating a 1.01% Potential Upside Amidst Healthcare Growth

Bausch + Lomb Corporation (NYSE: BLCO), a globally renowned name in the eye health sector, presents a complex picture for investors seeking opportunities in the healthcare industry. With a market..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 54.94% Potential Upside

Molina Healthcare Inc (NYSE: MOH), a key player in the healthcare sector, occupies a unique position in the market by focusing on providing managed healthcare services to low-income families and..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Navigating a Promising 42% Upside in the Biotech Sector

Madrigal Pharmaceuticals, Inc. (MDGL), a biotechnology firm based in West Conshohocken, Pennsylvania, is gaining attention in the healthcare sector for its pioneering approach to treating metabolic dysfunction-associated steatohepatitis (MASH). With..

Bruker Corporation (BRKR) Stock Analysis: Exploring a 30.71% Upside Potential

For investors with a keen eye on the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents an intriguing opportunity. As a prominent player in the medical devices industry, Bruker has established..

United Therapeutics Corporation (UTHR): Investor Outlook Reveals a 25% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a leading player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking exposure to..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 75.95% Potential Upside in the Biotechnology Sector

Legend Biotech Corporation (NASDAQ: LEGN) stands as a formidable player in the healthcare sector, specifically within the burgeoning biotechnology industry. With a market capitalization of $7.98 billion, Legend Biotech is..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Transitional Phase with Insightful Market Indicators

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the intersection of innovation and essential support services within the healthcare sector, specifically in diagnostics and research. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds